Anesthetic management for dental surgery in a child with glycogen storage disease type IIIa: a case report
10.17245/jdapm.2022.22.6.451
- Author:
Buğra AYKENAR
1
;
Nedim ÇEKMEN
Author Information
1. Baskent University, Faculty of Medicine, Department of Anesthesiology, Ankara, Turkey
- Publication Type:Case Report
- From:Journal of Dental Anesthesia and Pain Medicine
2022;22(6):451-455
- CountryRepublic of Korea
- Language:English
-
Abstract:
Glycogen storage disease (GSD) is a group of inherited disorders, which result in the deficiency of enzymes involved in glycogen metabolism, leading to an accumulation of glycogen in various organs. Deficiency of amylo-1-6-glicosidase (debranching enzyme) causes glycogen storage disease type III (GSD III). The main problems that anesthesiologists face in patients with GSD III include hypoglycemia, muscle weakness, delayed awakening due to abnormal liver function, possible difficulty in airway, and cardiomyopathy. In the face of these difficulties, airway preparation and appropriate glucose monitoring and support during the fasting period are important. The doses of the drugs to be used should be calculated considering the increased volume of distribution and decreased metabolic activity of the liver. We present the case of a child with GSD IIIa who underwent dental prosedation under general anesthesia. She was also being prepared for liver transplantation. This case was additionally complicated by the patient’s serious allergic reaction to eggs and milk.
